PrintyMed: Funding, Investors & Team (Oct 2026)
PrintyMed is a breakthrough medicine company that specializes in the creation of artificial spider silk for a variety of medical purposes. Despite the well-known applications of artificial spider silk, our team of scientists, engineers, and medical professionals is collaborating to develop a material that can be used to 3D print living tissue. This novel approach to medicine has the potential to transform the medical industry and improve the lives of millions. We are thrilled to be at the vanguard of this new technology, continually pushing the limits of what is possible.
PrintyMed has raised $590k across 2 funding rounds on record, the most recent an undisclosed round of $590k announced in May 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PrintyMed Company Profile and Key Stats
Latest funding round on record: May 2026.
PrintyMed Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
PrintyMed announced an undisclosed round in Apr 2026; the amount was not disclosed.
1 month later, an undisclosed round of $590k was announced in May 2026.
PrintyMed Founders and Leadership Team
No contact details are on record for this team yet.
PrintyMed Funding Compared to Other Biotechnology Startups
PrintyMed's latest round of $590k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PrintyMed in Biotechnology and Riga
Companies Similar to PrintyMed
BioLinker is a creation of manufactured science, protein blend packs, and protein.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
PrintyMed Funding FAQs
What does PrintyMed do?
PrintyMed is a breakthrough medicine company that specializes in the creation of artificial spider silk for a variety of medical purposes. Despite the well-known applications of artificial spider silk, our team of scientists, engineers, and medical professionals is collaborating to develop a material that can be used to 3D print living tissue. This novel approach to medicine has the potential to transform the medical industry and improve the lives of millions. We are thrilled to be at the vanguard of this new technology, continually pushing the limits of what is possible.
How much funding has PrintyMed raised?
PrintyMed has raised $590k across 2 rounds on record. The most recent is an undisclosed round of $590k announced in May 2026.
When did PrintyMed last raise funding?
PrintyMed's most recent funding round on record is an undisclosed round of $590k, announced in May 2026.
Who founded PrintyMed?
FundedIQ lists Jekaterina Romanova (Founder) at PrintyMed.
Where is PrintyMed headquartered?
PrintyMed is based in Riga, Riga, Latvia.
How many employees does PrintyMed have?
PrintyMed is in the 1-10 employee band.
How does PrintyMed's funding compare to other Biotechnology startups?
PrintyMed's latest round of $590k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's PrintyMed Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PrintyMed is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.